ELTEK director discloses 20,000 stock options

ELTEK LTD director Ilana Lurie reported existing equity awards in the form of employee stock options.

Rhea-AI Filing Summary

ELTEK LTD director Ilana Lurie reported existing equity awards in the form of employee stock options. She holds options over 10,000 ordinary shares at an exercise price of $5.8900 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.6700 per share expiring on October 6, 2033.

Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant dates in September 2021 and October 2023, and an additional 6.25% becoming exercisable at the end of each subsequent quarter.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lurie Ilana

Role Director

Type	Security	Shares	Price	Value
holding	Employee Stock Option	--	--	--
holding	Employee Stock Option	--	--	--

Holdings After Transaction: Employee Stock Option — 20,000 contracts (Direct)

Footnotes (2)

1. F1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021
2. F2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider holdings did ELTEK (ELTK) director Ilana Lurie report on Form 3?

Ilana Lurie reported holding employee stock options over 20,000 ELTEK ordinary shares in total. These options are split into two 10,000-share grants with different exercise prices and expiration dates, reflecting her existing equity-based compensation position as a director.

What are the exercise prices of Ilana Lurie’s ELTEK (ELTK) stock options?

Lurie’s reported options have exercise prices of $5.8900 and $8.6700 per share. Each price applies to a separate 10,000-share employee stock option grant, giving her the right to acquire ELTEK ordinary shares at those fixed prices if she chooses to exercise.

How many ELTEK (ELTK) shares underlie Ilana Lurie’s reported options?

Her Form 3 shows options over 10,000 underlying ordinary shares at $5.8900 and another 10,000 underlying ordinary shares at $8.6700. In total, 20,000 ELTEK ordinary shares are subject to these employee stock option awards, assuming full vesting and exercise.

When do Ilana Lurie’s ELTEK (ELTK) stock options expire?

The options with a $5.8900 exercise price expire on September 6, 2031, while those with a $8.6700 exercise price expire on October 6, 2033. These expiration dates define the periods during which she may exercise the options, subject to vesting.

How do Ilana Lurie’s ELTEK (ELTK) stock options vest over time?

Each option grant vests over four years. Twenty-five percent of the options become exercisable on the first anniversary of the grant date, and an additional 6.25% of the options become exercisable at the end of each subsequent quarter until fully vested, according to the option agreements.

What are the grant dates for Ilana Lurie’s ELTEK (ELTK) stock options?

The Form 3 footnotes state that one option grant was made on September 6, 2021 and the other on October 10, 2023. These grant dates determine the start of the four-year vesting schedules and the timing of the first 25% vesting for each award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:43 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lurie Ilana

(Last) (First) (Middle)

23 SHIVTEI

(Street)

MODIIN-MACCABIM- REUT 7178064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ELTEK LTD [ ELTK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option	(1)	09/06/2031	Ordinary share	10,000	$5.89	D
Employee Stock Option	(2)	10/06/2033	Ordinary share	10,000	$8.67	D

Explanation of Responses:

1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021

2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023

	/s/ Ilana Lurie	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)